Paper19720809
Development and first validation of the COPD Assessment Test.
Jones PW and 5 others. Eur Respir J, 2009. Cited by 2,534 papers, by iCite.
Cite this record
ConductScience Library. Development and first validation of the COPD Assessment Test. Papers, record 19720809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19720809
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Health Status Indicators | Major topic |
| Pulmonary Disease, Chronic Obstructive | Major topic |
| Surveys and Questionnaires | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Europe | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Predictive Value of Tests | |
| Psychometrics | |
| Quality of Life | |
| Reproducibility of Results | |
| United States |
Source PubMed
Trials29
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01880177 | Developing a COPD Case Finding Methodology for Primary Care | Background | ClinicalTrials.gov | |
| NCT02706600 | Trial of E-Health Platform Supported Care vs Usual Care After Exacerbation of COPD | Background | ClinicalTrials.gov | |
| NCT02706613 | Comparing Online Pulmonary Rehabilitation 'myPR' Versus Conventional Pulmonary Rehabilitation for Patients With COPD | Results | ClinicalTrials.gov | |
| NCT02838108 | The Relationship Between GOLD Risk Group and Clinical Outcomes in a Community-based COPD Cohort | Background | ClinicalTrials.gov | |
| NCT02973945 | High Flow Nasal Cannula and Aerobic Capacity Training | Results | ClinicalTrials.gov | |
| NCT03084796 | A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease | Background | ClinicalTrials.gov | |
| NCT03251781 | Minimal Important Difference for the Glittre-ADL Test and London Chest Activity of Daily Living Scale | Background | ClinicalTrials.gov | |
| NCT03322787 | Effect of Exercise Training Under HFO Device on Endurance Tolerance in Patients With COPD and CRF: a Randomized Controlled Study. | Background | ClinicalTrials.gov | |
| NCT03323190 | An Educational Intervention to Improve Disease Management Knowledge of Hospitalized Patients With COPD | Background | ClinicalTrials.gov | |
| NCT03355677 | A Study Into Airways Disease Case Finding and Management | Background | ClinicalTrials.gov | |
| NCT03692793 | Pulmonary Rehabilitation in Functional Outcomes and Its Relationship With Morbidity and Mortality in Patients With COPD | Background | ClinicalTrials.gov | |
| NCT04201548 | Different Modalities of Exercise Training in COPD With Chronic Respiratory Failure (CRF) | Background | ClinicalTrials.gov | |
| NCT04320342 | A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD | Background | ClinicalTrials.gov | |
| NCT04482634 | Tele-rehabilitation Versus Home Exercise Program in COVID-19 | Results | ClinicalTrials.gov | |
| NCT04584671 | Lung Structure-Function In Survivors of Mild and Severe COVID-19 Infection | Background | ClinicalTrials.gov | |
| NCT04616313 | Novel Pulmonary Imaging of Lung Structure and Function in E-cigarette Smokers | Background | ClinicalTrials.gov | |
| NCT04711057 | CENTR(AR): Lungs Moving | Background | ClinicalTrials.gov | |
| NCT04961060 | Drivers of Eosinophilic COPD Exacerbations | Background | ClinicalTrials.gov | |
| NCT05114434 | Effect of BDP/Formoterol/G on Cough Efficacy in Moderate to Severe COPD Patients (EFFICACE) | Results | ClinicalTrials.gov | |
| NCT05708443 | Effect of Combined Endurance Training on ADL and Walking in COPD Patients | Background | ClinicalTrials.gov |
Cited by1,662
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,534 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985238 | Case Finding for COPD in Nottingham and District (C FIND COPD). A Pilot Study of Uptake, Acceptability and Diagnostic Yield in a One-Stop Assessment Following Lung Cancer Screening. | Int J Chron Obstruct Pulmon Dis | 2026 | https://conductscience.org/library/papers/42985238 | PubMed |
| 42971626 | Predicting the persistence of Long COVID 36 months after hospitalisation: a prospective Ukrainian cohort study. | BMJ Open | 2026 | https://conductscience.org/library/papers/42971626 | PubMed |
| 42914145 | Tiotropium and clinically important deterioration in mild-to-moderate chronic obstructive pulmonary disease: a post hoc win ratio analysis of the Tie-COPD study. | BMJ Open Respir Res | 2026 | https://conductscience.org/library/papers/42914145 | PubMed |
| 42907865 | Repeatability and replicability of the Respiratory Symptom Experience Scale (RSES): internal and external validation of smoking-status differences in respiratory symptoms. | Health Qual Life Outcomes | 2026 | https://conductscience.org/library/papers/42907865 | PubMed |
| 42899053 | Effect of l-menthol on breathlessness and exercise endurance in COPD: a randomised crossover trial. | ERJ Open Res | 2026 | https://conductscience.org/library/papers/42899053 | PubMed |
| 42898520 | Latent classes and symptom network analysis of kinesiophobia in older adult patients with chronic obstructive pulmonary disease. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42898520 | PubMed |
| 42882316 | Multidimensional Inflammatory Biomarker Profiling in COPD: A Latent Inflammatory Construct Associated with Disease Severity and Exacerbation Burden. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42882316 | PubMed |
| 42882183 | Changes in Symptoms and Lung Function During Three Months of Individually Tailored Inhaled Therapy in Chronic Obstructive Pulmonary Disease: A Prospective Observational Cohort Study. | J Clin Med | 2026 | https://conductscience.org/library/papers/42882183 | PubMed |
| 42881582 | Changes in Physical Activity and Psychological Status in Patients with COPD Between Pre- and Post-COVID-19 Assessments: A Pilot Observational Longitudinal Cohort Study. | Healthcare (Basel) | 2026 | https://conductscience.org/library/papers/42881582 | PubMed |
| 42865803 | Symptoms improvement and lung function benefits of fixed triple therapy with beclomethasone/formoterol/glycopyrronium inhalation powder in patients with moderate-to-severe COPD: outcomes of the Bulgarian arm of the RESPONSE study. | J Thorac Dis | 2026 | https://conductscience.org/library/papers/42865803 | PubMed |
| 42856556 | Prevalence of anxiety and depression and diagnostic utility of the CAT scale in spirometry-confirmed COPD patients: Findings from the Chinese Population Health and Multimorbidities Study. | Chin Med J Pulm Crit Care Med | 2026 | https://conductscience.org/library/papers/42856556 | PubMed |
| 42831112 | A serum cytokine-derived integrated inflammatory profile score (IIPS) links systemic inflammation to symptom burden and severity in COPD. | PeerJ | 2026 | https://conductscience.org/library/papers/42831112 | PubMed |
| 42826262 | Cross-cultural adaptation and psychometric validation of the Arabic Leicester Cough Questionnaire in patients with chronic cough: A cross-sectional study. | Medicine (Baltimore) | 2026 | https://conductscience.org/library/papers/42826262 | PubMed |
| 42780717 | Chronic Obstructive Pulmonary Disease With Severe Airflow Limitation and Chronic Antitussive Use: Challenges in Diagnosis, Treatment Adherence, and Inhaler Technique: A Case Report. | Cureus | 2026 | https://conductscience.org/library/papers/42780717 | PubMed |
| 42776698 | COPD Assessment Test Variability as a Predictor of Exacerbations in Patients with COPD: A Prospective Study Using Virtual Assistant Monitoring. | Adv Respir Med | 2026 | https://conductscience.org/library/papers/42776698 | PubMed |
| 42775341 | Five-year changes in generic and disease-specific patient-reported outcome measures in stable COPD: a real-world cohort study. | Patient Relat Outcome Meas | 2026 | https://conductscience.org/library/papers/42775341 | PubMed |
| 42761771 | Insights into the Follow-Up of Patients with COPD in Daily Practice: Results from a Spanish Delphi Consensus ("The SEGUIPOC Study"). | Int J Chron Obstruct Pulmon Dis | 2026 | https://conductscience.org/library/papers/42761771 | PubMed |
| 42757587 | Prevalence and impact of insomnia in patients with chronic obstructive pulmonary disease. | Chron Respir Dis | 2026 | https://conductscience.org/library/papers/42757587 | PubMed |
| 42743080 | Emphysema Treatment Gap and Gender Differences in a Lung Cancer Screening Cohort. | Respiration | 2026 | https://conductscience.org/library/papers/42743080 | PubMed |
| 42741596 | The Questionnaire for O2 Therapy Evaluation (QuOTE): a simple O2 therapy assessment. | ERJ Open Res | 2026 | https://conductscience.org/library/papers/42741596 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19720809
GET https://conductscience.org/api/papers/v1/19720809/trials?page=2